A 2022 systematic review and meta-analysis published in JAMA Internal Medicine found that GLP-1 receptor agonist use was associated with increased risk of biliary disease, with an overall relative risk of approximately 1.37
Rather, it means healthcare providers must weigh potential benefits against theoretical risks on a case-by-case basis, informed by what is known about the drug's mechanism, molecular weight, and protein binding characteristics
Under the care of our Wellness practitioner we create personalized treatment plans to support your journey
The thigh offers a convenient, accessible injection site with predictable absorption patterns that support consistent weight loss outcomes
This gives it a more powerful metabolic effect
Since the weight loss curves were non-linear (significant in the first year, then a plateau), longer protocols could have brought the figures closer together